ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,167Medicare Part D Prescriptions Filled, Including Refills

Rank: 95 out of 939

$890K Total Retail Price of All Prescriptions

Rank: 64 out of 939

669 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 669 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 669 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 13,840 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 788 685 1 7
LEVOTHYROXINE SODIUM 561 517 2 4
POTASSIUM CHLORIDE 531 485 3 9
OMEPRAZOLE 428 353 4 5
SIMVASTATIN 406 361 5 2
LISINOPRIL 379 321 6 3
METFORMIN HCL 375 314 7 8
HYDROCODONE-ACETAMINOPHEN 356 288 S3 8 1
WARFARIN SODIUM 347 301 9 17
METOPROLOL TARTRATE 332 286 10 10
AMLODIPINE BESYLATE 281 258 11 6
DONEPEZIL HCL 245 231 12 30
TRAMADOL HCL 229 187 13 16
GABAPENTIN 209 199 14 11
LOSARTAN POTASSIUM 186 172 15 29
CITALOPRAM HBR 179 169 16 15
SERTRALINE HCL 172 136 17 24
DIOVAN 169 130 18 50
MELOXICAM 151 140 19 14
QUETIAPINE FUMARATE 150 133 20 69
HYDROCHLOROTHIAZIDE 148 132 21 12
CARBIDOPA-LEVODOPA 146 137 22 102
ATENOLOL 139 132 23 19
TRAZODONE HCL 133 106 24 26
ALLOPURINOL 131 124 25 31
CLONIDINE HCL 128 103 26 39
NAMENDA 126 113 27 49
METOPROLOL SUCCINATE 123 104 28 21
CARVEDILOL 123 123 28 25
DIGOXIN 123 111 28 45
LANTUS 122 103 31 59
NEXIUM 119 73 32 18
GLYBURIDE 118 115 R 33 89
ZOLPIDEM TARTRATE 117 75 34 20
POLYETHYLENE GLYCOL 3350 107 84 35 57
CLOPIDOGREL 102 91 36 28
PRAVASTATIN SODIUM 102 99 36 13
ALENDRONATE SODIUM 100 97 38 40
MIRTAZAPINE 100 77 38 56
RISPERIDONE 100 63 38 82
ENALAPRIL MALEATE 99 81 41 65
COMBIVENT 97 67 42 120
OXYBUTYNIN CHLORIDE 96 86 43 125
AGGRENOX 92 85 44 153
CEPHALEXIN 90 76 45 77
LEVOFLOXACIN 90 79 45 86
ESCITALOPRAM OXALATE 89 68 47 61
PROAIR HFA 86 62 48 41
CYCLOBENZAPRINE HCL 86 47 R 48 36
CIPROFLOXACIN HCL 82 70 50 54
OXYCODONE-ACETAMINOPHEN 82 54 S2 50 138
FENTANYL 79 61 S2 52 104
SEROQUEL 76 64 53 139
GLIMEPIRIDE 76 45 53 37
SYMBICORT 75 58 55 137
PAROXETINE HCL 74 50 56 70
SPIRONOLACTONE 73 67 57 71
FLUOXETINE HCL 71 49 58 47
BUMETANIDE 71 71 58 124
FOSINOPRIL SODIUM 67 67 60 199
TAMSULOSIN HCL 66 65 61 27
AMITRIPTYLINE HCL 64 44 R 62 38
TRIAMTERENE-HCTZ 63 62 63 33
SULFAMETHOXAZOLE-TRIMETHOPRIM 61 50 64 64
PREDNISONE 61 56 64 42
PLAVIX 61 60 64 48
DILTIAZEM ER 60 59 67 94
CYMBALTA 60 43 67 44
NIFEDIPINE ER 58 38 69 105
ISOSORBIDE MONONITRATE ER 58 56 69 53
METFORMIN HCL ER 58 49 69 76
LOVASTATIN 55 54 72 46
GEMFIBROZIL 55 44 72 100
AZITHROMYCIN 54 51 74 32
TERAZOSIN HCL 53 52 75 114
ADVAIR DISKUS 52 37 76 60
PANTOPRAZOLE SODIUM 51 50 77 66
DOXYCYCLINE HYCLATE 50 43 78 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.